FR2991878A1 - Drink, useful for depigmenting skin of human, comprises extract of vegetables including Physcomitrella patens, maize and Oryza sativa - Google Patents
Drink, useful for depigmenting skin of human, comprises extract of vegetables including Physcomitrella patens, maize and Oryza sativa Download PDFInfo
- Publication number
- FR2991878A1 FR2991878A1 FR1255516A FR1255516A FR2991878A1 FR 2991878 A1 FR2991878 A1 FR 2991878A1 FR 1255516 A FR1255516 A FR 1255516A FR 1255516 A FR1255516 A FR 1255516A FR 2991878 A1 FR2991878 A1 FR 2991878A1
- Authority
- FR
- France
- Prior art keywords
- beverage
- depigmenting
- maize
- oryza sativa
- physcomitrella patens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 8
- 240000008042 Zea mays Species 0.000 title claims abstract description 8
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 title claims abstract description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 title claims abstract description 8
- 235000009973 maize Nutrition 0.000 title claims abstract description 8
- 240000007594 Oryza sativa Species 0.000 title claims abstract description 7
- 241000195887 Physcomitrella patens Species 0.000 title claims abstract description 7
- 239000000284 extract Substances 0.000 title abstract description 3
- 235000013311 vegetables Nutrition 0.000 title abstract 2
- 235000013361 beverage Nutrition 0.000 claims description 43
- 239000002679 microRNA Substances 0.000 claims description 17
- 108091070501 miRNA Proteins 0.000 claims description 16
- 239000000419 plant extract Substances 0.000 claims description 12
- 108091085429 Physcomitrella patens miR1039 stem-loop Proteins 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 235000003599 food sweetener Nutrition 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 239000003765 sweetening agent Substances 0.000 claims description 7
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 108091066902 Homo sapiens miR-330 stem-loop Proteins 0.000 claims description 4
- 239000004097 EU approved flavor enhancer Substances 0.000 claims description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 150000007513 acids Chemical class 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 150000001413 amino acids Chemical class 0.000 claims description 3
- 229960001948 caffeine Drugs 0.000 claims description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 3
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 235000019264 food flavour enhancer Nutrition 0.000 claims description 3
- 239000003349 gelling agent Substances 0.000 claims description 3
- 239000002417 nutraceutical Substances 0.000 claims description 3
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 2
- 239000006286 aqueous extract Substances 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- -1 texturizers Substances 0.000 claims 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 13
- 210000003491 skin Anatomy 0.000 description 13
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 12
- 108700011259 MicroRNAs Proteins 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 108091030146 MiRBase Proteins 0.000 description 4
- 239000006180 TBST buffer Substances 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- 235000020415 coconut juice Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000002752 melanocyte Anatomy 0.000 description 2
- 230000003061 melanogenesis Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 101100130886 Candida albicans (strain SC5314 / ATCC MYA-2876) MNT1 gene Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 101000923835 Homo sapiens Low density lipoprotein receptor adapter protein 1 Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 239000012097 Lipofectamine 2000 Substances 0.000 description 1
- 102100034389 Low density lipoprotein receptor adapter protein 1 Human genes 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 241000209094 Oryza Species 0.000 description 1
- 108091078012 Oryza sativa miR1428e stem-loop Proteins 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 101100454113 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) KRE2 gene Proteins 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000020400 fruit nectar Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 108091034299 miR168a stem-loop Proteins 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940109529 pomegranate extract Drugs 0.000 description 1
- 230000007859 posttranscriptional regulation of gene expression Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 238000003156 radioimmunoprecipitation Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940045613 taurine 1000 mg Drugs 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 229940089133 vitamin b6 5 mg Drugs 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9739—Bryophyta [mosses]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
Description
Boisson dépigmentante La présente invention concerne une boisson dépigmentante, destinée à dépigmenter la peau, notamment la peau humaine, comprenant un miRNA ou un extrait végétal. La pigmentation de la peau est une problématique esthétique notamment chez les femmes, mais qui devient de plus en plus sensible dans une fraction non négligeable des hommes. Une pigmentation non uniforme peut se présenter, par exemple, sous forme de taches de vieillesse ou d'irrégularités pigmentaires.The present invention relates to a depigmenting beverage for depigmenting the skin, especially human skin, comprising a miRNA or a plant extract. The pigmentation of the skin is an aesthetic problem, especially for women, but it is becoming more and more sensitive in a not insignificant fraction of men. Non-uniform pigmentation may occur, for example, in the form of age spots or pigment irregularities.
Trois pigments sont responsables de la couleur de peau, de par leur répartition en surface : le carotène, l'hémoglobine et la mélanine. Parmi ces trois pigments, la mélanine est le pigment le plus important de la peau : son taux et sa composition exacte (eumélanine ou pheomélanine) dans la peau détermine sa couleur. La mélanine est produite à partir de la tyrosine avec le concours de différentes enzymes impliquées dans la mélanogenèse, dont la tyrosinase.Three pigments are responsible for the skin color, by their surface distribution: carotene, hemoglobin and melanin. Among these three pigments, melanin is the most important pigment of the skin: its level and its exact composition (eumelanin or pheomelanin) in the skin determines its color. Melanin is produced from tyrosine with the help of various enzymes involved in melanogenesis, including tyrosinase.
Afin d'uniformiser la couleur de la peau, il est connu d'appliquer sur la peau des compositions cosmétiques dépigmentantes, telles que des crèmes blanchissantes. Ces crèmes comprennent notamment des actifs dépigmentants.In order to standardize the color of the skin, it is known to apply on the skin depigmenting cosmetic compositions, such as whitening creams. These creams include depigmenting actives.
Des exemples de tels actifs sont l'hydroquinone, l'acide kojique, ou encore l'acide azélaïque.Examples of such actives are hydroquinone, kojic acid, or azelaic acid.
Toutefois, il subsiste toujours le besoin de proposer de nouveaux produits pour dépigmenter la peau, qui soient plus efficaces et plus faciles à administrer.However, there is still a need for new products to depigment the skin that are more effective and easier to administer.
En outre, compte tenu de la recherche toujours croissante par les consommateurs de produits non toxique, non immunogène, biologiquement dégradable et des contraintes réglementaires de plus en plus lourdes pesant sur les composés issus de l'industrie chimique, il serait souhaitable que ces produits soient d'origine naturelle. Il a déjà été démontré que certains miRNAs humains peuvent diminuer la production de mélanine par les enzymes impliquées dans la mélanogenèse (FR 1161950).In addition, in view of the ever-growing quest for non-toxic, non-immunogenic, biologically degradable products and the increasingly burdensome regulatory burdens on chemicals from the chemical industry, it is desirable that these products be of natural origin. It has already been shown that certain human miRNAs can decrease the production of melanin by the enzymes involved in melanogenesis (FR 1161950).
De plus, Zhang et al. ont démontré que l'expression de certaines gènes chez des souris pouvait être régulée par des miRNAs végétaux (Zhang et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res. 2012 Jan;22(1):107-26). Or la Demanderesse a démontré que le niveau de mélanine dans les mélanocytes humains était réduit lorsque les cellules étaient traitées avec des mimétiques de miRNA humains produits par des plantes et que l'ingestion par voie orale de miRNAs végétaux spécifiques altère le niveau de mélanine dans les mélanocytes humains dans la peau. Par conséquent, la présente invention a pour objet une boisson dépigmentante, notamment de la peau humaine, comprenant au moins un des miRNAs végétaux choisi parmi : ppt-miR1039-5p, zma-miR528a*, osa-miR4128e-5p et hsamir330.In addition, Zhang et al. demonstrated that expression of certain genes in mice could be regulated by plant miRNAs (Zhang et al., Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA Cell Res 2012 Jan; 22 (1 ): 107-26). However, the Applicant has demonstrated that the level of melanin in human melanocytes was reduced when the cells were treated with plant-produced human miRNA mimetics and that oral ingestion of specific plant miRNAs alters the level of melanin in the cells. human melanocytes in the skin. Therefore, the subject of the present invention is a depigmenting beverage, in particular human skin, comprising at least one of the plant miRNAs chosen from: ppt-miR1039-5p, zma-miR528a *, osa-miR4128e-5p and hsamir330.
Par « microRNAs (miRNAs) », on entend des RNAs non-codant d'environ 21 nucléotides de longueur. Il a été démontré qu'ils jouent un rôle crucial dans la régulation post-transcriptionnelle d'expression des gènes, par exemple en affectant le taux de traduction ou en déstabilisant l'ARNm cible (Friedman RC et al., Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105).By "microRNAs (miRNAs)" is meant non-coding RNAs of about 21 nucleotides in length. They have been shown to play a crucial role in the post-transcriptional regulation of gene expression, for example by affecting the rate of translation or destabilizing the target mRNA (Friedman RC et al., Most mammalian mRNAs are conserved targets of microRNAs, Genome Res 2009, 19: 92-105).
Les miRNAs, actuellement connus, sont répertoriés notamment dans la base www.mirbase.org. Le ppt-miR1039-5p est un miRNA se trouvant dans l'extrait de plante entière, notamment les rhizoides, les feuilles, la tige, et les méristèmes, de Physcomitrella patens, une espèce de mousse courante dans l'hémisphère nord. Le miRNA ppt-miR1039-5p, a pour numéro d'accession MIMAT0005148 dans mirbase et pour séquence 5'-UCU UUG GGU CUU UCU CUC CUG-3' (SEQ ID NO : 1). Le zma-miR528a* est un miRNA se trouvant dans l'extrait de plante entière, notamment la racine, les feuilles, la tige, les méristèmes, les grains, les fleurs et les fruits, de Maize, connu largement comme le mals. Le miRNA zma-miR528a* a pour numéro d'accession MIMAT0015362 dans mirbase et pour séquence 5'-CCU GUG CCU GCC UCU UCC AUU-3' (SEQ ID NO : 2). Le miRNA osa-miR1428e-5p est un miRNA se trouvant dans l'extrait de plante entière, notamment la racine, les, feuille, la tige, les méristèmes, les graines, les fleurs et les fruits, d'Oryza sativa, une espèce de riz poussant originellement en Asie. Le miRNA osa-miR4128e-5p a pour numéro d'accession MIMAT0007784 dans mirbase et pour séquence 5'-AAU UCA CAG GCC CUA UCU UGU G-3' (SEQ ID NO : 3).The miRNAs, currently known, are listed in the base www.mirbase.org. Ppt-miR1039-5p is a miRNA found in the whole plant extract, including rhizoids, leaves, stem, and meristems, of Physcomitrella patens, a common moss species in the northern hemisphere. The miRNA ppt-miR1039-5p, has accession number MIMAT0005148 in mirbase and for sequence 5'-UCU UCG UCU UCU UCU CUG UG-3 '(SEQ ID NO: 1). Zma-miR528a * is a miRNA found in the whole plant extract, including the root, leaves, stem, meristems, grains, flowers and fruits of Maize, widely known as maize. The miRNA zma-miR528a * has accession number MIMAT0015362 in mirbase and for sequence 5'-CCU GUG CCU GCC UUC UCU UU-3 '(SEQ ID NO: 2). MiRNA osa-miR1428e-5p is a miRNA found in the whole plant extract, including the root, leaves, stem, meristems, seeds, flowers and fruits of Oryza sativa, a species of rice originally growing in Asia. The miRNA osa-miR4128e-5p has accession number MIMAT0007784 in mirbase and for sequence 5'-AAU UCA CAG GCC UCU UCU UGU G-3 '(SEQ ID NO: 3).
Le miRNA hsa-mir330 est un miRNA se trouvant dans l'ARN humain. Le miRNA hsa-mir330 a pour numéro d'accession MI0000803 dans mirbase et pour séquence 5'- CUU UGG CGA UCA CUG CCU CUC UGG GCC UGU GUC UUA GGC UCU GCA AGA UCA ACC GAG CAA AGC ACA CGG CCU GCA GAG AGG CAG CGC UCU GCC C-3'(SEQ ID NO : 4). La boisson selon l'invention peut avantageusement comprendre ledit miRNA en une proportion allant de 0,0001 % à 10 % et de préférence de de 0,001 % à 1 % en poids, par rapport au poids total de la boisson. La présente invention a également pour objet une boisson dépigmentante comprenant au moins un des extraits végétaux choisi parmi : Physcomitrella patens, Maize et Oryza sativa. La boisson selon l'invention peut avantageusement comprendre les trois extraits végétaux : Physcomitrella patens, Maize et Oryza sativa. La boisson selon l'invention peut avantageusement comprendre ledit extrait végétal en une proportion allant de 0,0001 % à 10 % et de préférence de 0,001 % à 1 % en poids, par rapport au poids total de la boisson. L'extrait végétal utilisable dans la présente invention peut être issu de plante entière, notamment la racine, les feuilles, la tige, les méristèmes, les graines, les fleurs et les fruits. Cet extrait peut être obtenu à l'aide de tout solvant et préférentiellement en utilisant un solvant aqueux, alcoolique ou huileux. 25 30 Par ( solvant aqueux », on entend un solvant contenant majoritairement de l'eau. Par « solvant alcoolique », on entend un solvant choisi parmi les mono-alcools tels que le méthanol, l'éthanol ou l'isopropanol, et les glycols tels que le propylène glycol ou le dipropylène glycol, éventuellement en présence d'eau. Par « solvant huileux », on entend un solvant choisi parmi les huiles alimentaires.MiRNA hsa-mir330 is a miRNA found in human RNA. The miRNA hsa-mir330 has accession number MI0000803 in mirbase and for sequence 5'- CUU UGG CGA UCA CUG CCU CUC UGG GCC UGU GUC UUA GGC UCU GCA AGA UCA ACC GAG CAA AGC ACA CGG CCU GCA GAG AGG CAG CGC UCU GCC C-3 '(SEQ ID NO: 4). The beverage according to the invention may advantageously comprise said miRNA in a proportion ranging from 0.0001% to 10% and preferably from 0.001% to 1% by weight, relative to the total weight of the beverage. The present invention also relates to a depigmenting beverage comprising at least one of the plant extracts selected from: Physcomitrella patens, Maize and Oryza sativa. The drink according to the invention may advantageously comprise the three plant extracts: Physcomitrella patens, Maize and Oryza sativa. The beverage according to the invention may advantageously comprise said plant extract in a proportion ranging from 0.0001% to 10% and preferably from 0.001% to 1% by weight, relative to the total weight of the beverage. The plant extract that can be used in the present invention can be derived from whole plants, in particular the root, the leaves, the stem, the meristems, the seeds, the flowers and the fruits. This extract can be obtained using any solvent and preferably using an aqueous solvent, alcoholic or oily. By "aqueous solvent" is meant a solvent containing predominantly water. "Alcoholic solvent" means a solvent selected from monoalcohols such as methanol, ethanol or isopropanol, and glycols such as propylene glycol or dipropylene glycol, optionally in the presence of water "Oily solvent" means a solvent chosen from edible oils.
Outre le miRNA précédemment décrit, la boisson selon la présente invention peut également comprendre au moins un additif usuel dans le domaine agro-alimentaire. Notamment selon un mode de réalisation préféré, la boisson selon l'invention peut comprendre, de manière non limitative, un ou plusieurs des additifs suivants: - un ou plusieurs édulcorants tels que le glucose, et/ou édulcorants alternatifs (en anglais, « alternative sweeteners ») tels que l'aspartame, le sucralose, le sorbitol, d'autres polyols, ou l'acésulfame potassium. Lesdits édulcorants et/ou édulcorants alternatifs peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - un ou plusieurs texturisants et/ou gélifiants tels que la gomme de xanthane, le carraghénane, la pectine, ou les composés cellulosiques. Lesdits texturisants et/ou gélifiants peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - un ou plusieurs nutraceutiques tels que les minéraux (Ca2+, Mg2+...), les vitamines (A, B, C, D, K."), les probiotiques, les jus et nectars de fruit, l'eau de coco, ou les antioxydants tels que l'extrait de grenade.In addition to the miRNA previously described, the beverage according to the present invention may also comprise at least one additive that is customary in the agri-food field. In particular, according to a preferred embodiment, the beverage according to the invention may comprise, in a nonlimiting manner, one or more of the following additives: one or more sweeteners such as glucose, and / or alternative sweeteners (in English, "alternative sweeteners ") such as aspartame, sucralose, sorbitol, other polyols, or acesulfame potassium. Said alternative sweeteners and / or sweeteners may be present in the beverage at a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; one or more texturizers and / or gelling agents such as xanthan gum, carrageenan, pectin, or cellulosic compounds. Said texturizers and / or gelling agents may be present in the beverage at a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; one or more nutraceuticals such as minerals (Ca2 +, Mg2 +), vitamins (A, B, C, D, K), probiotics, fruit juices and nectars, coconut water, or antioxidants such as pomegranate extract.
Lesdits nutraceutiques peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - un ou plusieurs émulsifiants. Lesdits émulsifiants peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - un ou plusieurs conservateurs tels que les phénols ramifiés ou les biocides (les sorbates, les propionates, ou les benzoates). Lesdits conservateurs peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - un ou plusieurs acides tels que l'acide citrique. Lesdits acides peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - un ou plusieurs colorants et/ou arômes alimentaires. Lesdits colorants et/ou arômes alimentaires peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - un ou plusieurs parfums et/ou exhausteurs de goût. Lesdits parfums et/ou exhausteurs de goût peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson ; - un ou plusieurs acides aminés et/ou protéines tels que le collagène ou l'élastine. Lesdits acides aminés et/ou protéines peuvent être présents dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson ; - la caféine, pouvant être présente dans la boisson en une teneur de l'ordre de 0,001 à 30 % en poids, par rapport au poids total de la boisson; - et leurs mélanges, sans que cette liste ne soit limitative. Des exemples de tels additifs sont cités notamment dans Food and Beverage Additives - US Industry Study with Forecasts for 2014 & 2019 (Freedonia group) qui décrit une grande variété d'additifs alimentaires habituellement utilisés dans l'industrie agro-alimentaire, qui conviennent pour être utilisés comme ingrédients additionnels dans la boisson dépigmentante selon la présente invention. La présente invention a aussi pour objet l'utilisation de la boisson dépigmentante selon l'invention, pour dépigmenter la peau, notamment la peau humaine.Said nutraceuticals can be present in the beverage in a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; one or more emulsifiers. Said emulsifiers may be present in the beverage at a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; one or more preservatives such as branched phenols or biocides (sorbates, propionates, or benzoates). Said preservatives may be present in the beverage at a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; one or more acids such as citric acid. Said acids may be present in the beverage in a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; one or more dyes and / or food flavorings. Said dyes and / or food flavors may be present in the beverage at a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; - one or more perfumes and / or flavor enhancers. Said perfumes and / or flavor enhancers may be present in the beverage at a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; one or more amino acids and / or proteins such as collagen or elastin. Said amino acids and / or proteins may be present in the beverage at a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; caffeine, which may be present in the beverage in a content of the order of 0.001 to 30% by weight, relative to the total weight of the beverage; - and their mixtures, without this list being exhaustive. Examples of such additives are cited in particular in Food and Beverage Additives - US Industry Study with Forecasts for 2014 & 2019 (Freedonia group) which describes a wide variety of food additives commonly used in the food industry, which are suitable for used as additional ingredients in the depigmenting beverage according to the present invention. The present invention also relates to the use of the depigmenting beverage according to the invention, for depigmenting the skin, in particular human skin.
La boisson de la présente invention peut par exemple être prise une à deux fois par jour, avant et/ou après le repas.The beverage of the present invention may for example be taken once or twice daily, before and / or after the meal.
Cette boisson peut être fournie aux consommateurs sous différentes formes telles qu'en canette, en bouteille ou en brique en carton. EXEMPLES Exemple 1 : traitement avec ppt-miR1039-5p Matériel et Méthodes Cellules Des cellules pigmentées de mélanome humain MNT-1 (Reish et al., 1995) ont été cultivées dans du milieu RPMI1640 (# 21875, Gibco), avec 10% de sérum de veau foetal (# 10270, Gibco), 1% de pénicilline-streptomycine (# 15140, Gibco) et 1% de L-glutamine (# 25030, Gibco), à 37°C et 5% de CO2 en atmosphère humide. Mimétiques des miRNA 4x105 de cellules MNT-1 ont été ensemencés par puits dans une plaque à 6 puits (# 353046, Falcon) au jour -1. Au jour 0, les cellules ont été transfectées avec 50 et 100 nM de mimétique de miRNA (ppt-miR1039-5p, Qiagen MSY0005148), en utilisant 5uL de Lipofectamine 2000 (# 1668-019, Invitrogen).This drink can be provided to consumers in various forms such as can, bottle or cardboard brick. EXAMPLES Example 1: Treatment with ppt-miR1039-5p Materials and Methods Cells Human MNT-1 melanoma pigmented cells (Reish et al., 1995) were cultured in RPMI1640 medium (# 21875, Gibco), with 10% fetal calf serum (# 10270, Gibco), 1% penicillin-streptomycin (# 15140, Gibco) and 1% L-glutamine (# 25030, Gibco), at 37 ° C and 5% CO2 in a humid atmosphere. 4x105 miRNA mimetics of MNT-1 cells were inoculated per well in a 6-well plate (# 353046, Falcon) at day -1. At day 0, the cells were transfected with 50 and 100 nM miRNA mimetic (ppt-miR1039-5p, Qiagen MSY0005148), using 5uL of Lipofectamine 2000 (# 1668-019, Invitrogen).
Au jour 1, le milieu a été changé. Au jour 3, les cellules ont été trypsinées et ensemencées à 4x105 cellules par puits.On day 1, the medium was changed. At day 3, the cells were trypsinized and seeded at 4x105 cells per well.
Au jour 4, les cellules ont été transfectées de nouveau avec 50 nM de mimétique des miRNA (voir jour 0). Au jour 5, le milieu a été changé. Au jour 7, les cellules ont été trypsinées et ensemencées à 4x105 cellules par puits. Au jour 8, une plaque de six puits a été utilisée pour la lyse de l'ARN et l'autre pour la lyse des protéines.At day 4, cells were re-transfected with 50 nM miRNA mimetic (see day 0). On day 5, the medium was changed. At day 7, the cells were trypsinized and seeded at 4x105 cells per well. At day 8, a six-well plate was used for RNA lysis and the other for protein lysis.
Western blot Les protéines ont été extraites d'une plaque de six puits pendant 30 minutes à 4°C en utilisant 75pL de tampon de radio-immunoprécipitation (RIPA) (1% NP40, 0.5% de désoxycholate de sodium, 0,1% SDS dans du PBS) avec des inhibiteurs de protéase (Roche). Les lysats de protéines ont été centrifugés pendant 30 min à 14 000 rpm à 4°C. Le surnageant a été transféré dans un tube Eppendorf 1,5 ml pré-refroidi et placé sur la glace. La concentration en protéines a été déterminée avec le BCA Protein Assay (ThermoFisher). Les protéines (50pg) ont été séparées sur un gel 10% SDS-polyacrylamide et transférées sur des membranes de nitrocellulose ProTron (Whatman) à 100V pendant lh à température ambiante. Les membranes ont été saturées avec 5 de poudre de lait écrémé dans une solution Tris saline tamponnée (SCT). Les membranes ont été sondées avec l'anticorps primaire dilué (voir ci-dessous) dans 0,5% (v / v) de Tween / SCT (TTBS) pendant la nuit, puis soumises à trois lavages de cinq minutes chacun dans TTBS. Les anticorps secondaires ont été dilués dans du TTBS 1:10,000 et appliqués pendant lh à température ambiante. Les membranes sont ensuite lavées trois fois dans TTBS pendant 10min chacune et développées avec la solution chimioluminescente SuperSignal WestPico (Thermoscientific) à l'aide d'Amersham Hyperfilm (GE Healthcare). Les anticorps primaires utilisés sont les suivants : - Polyclonal de chèvre anti-Tyr (C-19), SC-7833 (Santa Cruz), dilué à 1 / 1,000 - Monoclonal de souris anti-13-actine (CA-15), A5441 (Sigma), 1 / 7,500 Les anticorps secondaires utilisés sont les suivants : - IgG anti-souris HRP, W402B (Promega), 1 / 10 000 - Anti-IgG de chèvre HRP, 705-035-147 (Jackson ImmunoResearch), 1 / 10 000.Western blot The proteins were extracted from a six-well plate for 30 minutes at 4 ° C using 75 μL of radioimmunoprecipitation buffer (RIPA) (1% NP40, 0.5% sodium deoxycholate, 0.1% SDS in PBS) with protease inhibitors (Roche). Protein lysates were centrifuged for 30 min at 14,000 rpm at 4 ° C. The supernatant was transferred to a 1.5 ml Eppendorf tube pre-cooled and placed on ice. Protein concentration was determined with BCA Protein Assay (ThermoFisher). Proteins (50 μg) were separated on a 10% SDS-polyacrylamide gel and transferred to ProTron nitrocellulose membranes (Whatman) at 100V for 1h at room temperature. The membranes were saturated with skim milk powder in buffered saline Tris (SCT) solution. The membranes were probed with the diluted primary antibody (see below) in 0.5% (v / v) Tween / SCT (TTBS) overnight, and then subjected to three washes of five minutes each in TTBS. Secondary antibodies were diluted in 1: 10,000 TTBS and applied for 1h at room temperature. The membranes are then washed three times in TTBS for 10 min each and developed with SuperSignal WestPico Chemiluminescent Solution (Thermoscientific) using Amersham Hyperfilm (GE Healthcare). The primary antibodies used are the following: - Anti-Tyr goat polyclonal (C-19), SC-7833 (Santa Cruz), diluted to 1 / 1,000 - Anti-13-actin mouse monoclonal (CA-15), A5441 (Sigma), 1 / 7,500 The secondary antibodies used are: - HRP anti-mouse IgG, W402B (Promega), 1 / 10,000 - Goat Anti-IgG HRP, 705-035-147 (Jackson ImmunoResearch), 1 / 10,000.
Résultats Il est à noter que l'ajout de 50nM de ppt-miR1039-5p a réduit la quantité de tyrosinase par rapport à l'essai contrôle, et qu'une plus grande diminution de la quantité de tyrosine est observée en cas d'ajout de 100nM de ppt- miR1039-5p (Figure 1). Ces résultats montrent que pptmiR1039-5p diminue la quantité de tyrosinase dans les cellules MNT1.Results It should be noted that the addition of 50nM of ppt-miR1039-5p reduced the amount of tyrosinase compared to the control test, and that a greater decrease in the amount of tyrosinase is observed in case of addition. 100nM of ppt-miR1039-5p (Figure 1). These results show that pptmiR1039-5p decreases the amount of tyrosinase in MNT1 cells.
Exemple 2 : une composition de boisson dépigmentante Une boisson dépigmentante avec la composition a) ou b) suivante a été préparée. miRNA(ppt-miR1039-5p) Composition a) Eau de coco 25 Lactosérum reconstitué 25 % Jus de grenade et de fruits rouges 5 % Stabilisant : pectine 0,1 % Acidifiant : acide citrique 0,1 % Eau QSP 100m1 Composition b) Caféine 80 mg Taurine 1000 mg D-glucuronalactone 600 mg Vitamine B2 1,5 mg Vitamine B3 20,5 mg Vitamine B5 5 mg Vitamine B6 5 mg Vitamine B12 5 pg Eau QSP 100m1Example 2: A depigmenting beverage composition A depigmenting beverage with the following composition a) or b) was prepared. miRNA (ppt-miR1039-5p) Composition a) Coconut water 25 Reconstituted whey 25% Pomegranate and red fruit juice 5% Stabilizer: pectin 0.1% Acidifier: citric acid 0.1% Water QSP 100m1 Composition b) Caffeine 80 mg Taurine 1000 mg D-glucuronalactone 600 mg Vitamin B2 1.5 mg Vitamin B3 20.5 mg Vitamin B5 5 mg Vitamin B6 5 mg Vitamin B12 5 pg Water QSP 100m1
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1255516A FR2991878A1 (en) | 2012-06-13 | 2012-06-13 | Drink, useful for depigmenting skin of human, comprises extract of vegetables including Physcomitrella patens, maize and Oryza sativa |
CN201310240319.7A CN103478826A (en) | 2012-06-13 | 2013-06-09 | Decoloration beverage |
KR1020130066093A KR20130139773A (en) | 2012-06-13 | 2013-06-10 | Depigmenting beverage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1255516A FR2991878A1 (en) | 2012-06-13 | 2012-06-13 | Drink, useful for depigmenting skin of human, comprises extract of vegetables including Physcomitrella patens, maize and Oryza sativa |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2991878A1 true FR2991878A1 (en) | 2013-12-20 |
Family
ID=46634393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1255516A Withdrawn FR2991878A1 (en) | 2012-06-13 | 2012-06-13 | Drink, useful for depigmenting skin of human, comprises extract of vegetables including Physcomitrella patens, maize and Oryza sativa |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR20130139773A (en) |
CN (1) | CN103478826A (en) |
FR (1) | FR2991878A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240556A (en) * | 2000-03-02 | 2001-09-04 | Doomaa Kk | Beautifying constituent extrected from germinating brown rice |
JP2002255784A (en) * | 2001-03-02 | 2002-09-11 | Oriza Yuka Kk | Composition for beautiful skin |
JP2005000177A (en) * | 2004-09-21 | 2005-01-06 | Soken Kk | Beauty beverage and beauty food |
WO2007073122A1 (en) * | 2005-12-23 | 2007-06-28 | Doosan Corporation | Composition for protecting and improving skin comprising the rice bran fermented by lactic acid bacteria |
JP2010235548A (en) * | 2009-03-31 | 2010-10-21 | Maruzen Pharmaceut Co Ltd | Antioxidant agent, anti-inflammatory agent, skin whitening ing agent, anti-aging agent, hair growing agent, and antiobesity agent, as well as cosmetic and food and drink |
CN102038262A (en) * | 2010-12-30 | 2011-05-04 | 东莞市德亨饮料食品有限公司 | Corn juice beverage with beautifying function and method for preparing same |
-
2012
- 2012-06-13 FR FR1255516A patent/FR2991878A1/en not_active Withdrawn
-
2013
- 2013-06-09 CN CN201310240319.7A patent/CN103478826A/en active Pending
- 2013-06-10 KR KR1020130066093A patent/KR20130139773A/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240556A (en) * | 2000-03-02 | 2001-09-04 | Doomaa Kk | Beautifying constituent extrected from germinating brown rice |
JP2002255784A (en) * | 2001-03-02 | 2002-09-11 | Oriza Yuka Kk | Composition for beautiful skin |
JP2005000177A (en) * | 2004-09-21 | 2005-01-06 | Soken Kk | Beauty beverage and beauty food |
WO2007073122A1 (en) * | 2005-12-23 | 2007-06-28 | Doosan Corporation | Composition for protecting and improving skin comprising the rice bran fermented by lactic acid bacteria |
JP2010235548A (en) * | 2009-03-31 | 2010-10-21 | Maruzen Pharmaceut Co Ltd | Antioxidant agent, anti-inflammatory agent, skin whitening ing agent, anti-aging agent, hair growing agent, and antiobesity agent, as well as cosmetic and food and drink |
CN102038262A (en) * | 2010-12-30 | 2011-05-04 | 东莞市德亨饮料食品有限公司 | Corn juice beverage with beautifying function and method for preparing same |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Week 201140, Derwent World Patents Index; AN 2011-G29539 * |
Also Published As
Publication number | Publication date |
---|---|
KR20130139773A (en) | 2013-12-23 |
CN103478826A (en) | 2014-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Weston | Bioactive products from fruit of the feijoa (Feijoa sellowiana, Myrtaceae): A review | |
JP6681974B2 (en) | Composition for skin whitening containing β-mangostin as an active ingredient | |
EP3060228B1 (en) | Lipid extract of passion fruit seeds | |
KR102536371B1 (en) | Composition Comprising Lactobacillus rhamnosus, Culture Fluid, or Culture Fluid Extract thereof with Anti-Inflammatory, Moisturizing, Skin Barrier, and Skin Cell Regeneration Property as Active Ingredient | |
JP2021509413A (en) | Kapok tree flower extract and cosmetological, pharmaceutical or dermatological compositions containing it | |
KR101837446B1 (en) | Composition for improving skin wrinkle or skin moisturing comprising alpha-, beta-, gamma-mangostin or gartanin compound as effective component | |
KR102526287B1 (en) | Composition for anti-inflammation and anti-wrinkle comprising fermentative product of Gryllus bimaculatus extract as effective component | |
KR101591499B1 (en) | Composition for skin whitening comprising amaranthus spp. l. extract or fraction thereof | |
KR102536160B1 (en) | Carbohydrate hydrolase reaction product of primula veris extract, preparation method thereof, and anti-aging composition comprising same | |
KR101772494B1 (en) | COMPOSITION OF SKIN WHITENING CONTAINING EXTRACT OF Sargassum horneri AND METHOD OF MAKING THE SAME | |
KR101742830B1 (en) | Deodorant composition comprising peroxidase and effective under neutral conditions | |
KR102058022B1 (en) | Composition for antioxidant and anti-inflammatory comprising fraction of Ledum palustre L. extract as effective component | |
FR2991878A1 (en) | Drink, useful for depigmenting skin of human, comprises extract of vegetables including Physcomitrella patens, maize and Oryza sativa | |
KR101483872B1 (en) | Composition for anti-wrinkling comprising fractions from leaves of quercus mongolica | |
KR102534239B1 (en) | Cosmetic composition comprising glutathione, Maqui Berry extract and Mulberry root extract | |
KR101250188B1 (en) | Skin whitening composition comprising extracts of Oryza sativa cv. chilbo | |
KR102337346B1 (en) | Cosmetic composition containing extract of Pinus rigida Mill. for antioxidative or anti-aging | |
KR101665753B1 (en) | Composition comprising miRNA 675 for suppressing production of melanogenesis | |
FR3106756A1 (en) | Cosmetic, nutraceutical or dermatological use of an extract of Tamarindus indicaL. and / or a composition comprising it | |
KR20200031055A (en) | Cosmetic composition for anti-wrinkle and enhancing elasticity comprising fermented extract of Phragmites Communis | |
KR102613802B1 (en) | Composition for skin whitening comprising culture of Lactobacillus reuteri and extract of Cnidium Monnieri | |
JP2019210236A (en) | Methods of making tomatidine or esculeogenin and products using tomatidine or esculeogenin | |
KR101933835B1 (en) | Skin whitening composition comprising plumbagin and ginger extract | |
KR102326086B1 (en) | Composition for Improving Skin Conditions Having Skin Whitening, Moisturizing, Anti-Wrinkle and Skin Barrier Property Comprising Complex Extracts of Broussonetia kazinoki as Active Ingredient | |
KR102600558B1 (en) | Composition for promoting hair growth and preventing hair loss comprising atraric acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20150227 |